Advanced search×

Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery.

PLoS One 5(8):e12310 (2010) PMID 20808818

While there is significant interest in combining anti-angiogenesis therapy with conventional anti-cancer treatment, clinical trials have as of yet yielded limited therapeutic gain, mainly because mechanisms of anti-angiogenic therapy remain to a large extent unknown. Currently, anti-angiogenic tumor therapy is conceptualized to either "normalize" dysfunctional tumor vasculature, or to prevent recruitment of circulating endothelial precursors into the tumor. An alternative biology, restricted to delivery of anti-angiogenics immediately prior to single dose radiotherapy (radiosurgery), is provided in the present study.

DOI: 10.1371/journal.pone.0012310
Version: za2963e q8za7 q8zbb q8zcf q8zd5 q8zea q8zf7 q8zg5

Similar articles you may find interesting…

  1. Predictors of Local Control After Single-Dose Stereotactic Image-Guided Intensity-Modulated Radiotherapy for Extracranial Metastases

    Int J Radiat Oncol Biol Phys 79(4):7 (2011) PMID 20510537

    The overall actuarial local relapse-free survival (LRFS) rate was 64% at a median follow-up of 18 months (range, 2-45 months). The median time to failure was 9.6 months (range, 1-23 months). On univariate analysis, LRFS was significantly correlated with prescription dose (p = 0.029). Stratification...
  2. Acid sphingomyelinase in macrophage biology.

    Cell Mol Life Sci 68(20):3293-305 (2011) PMID 21533981 PMCID PMC3178716

    We bring together studies on ASMase, its different forms and locations that are necessary for the macrophage to accomplish its diverse functions. We also address the importance of ASMase to several disease processes that are mediated by activated macrophages....
  3. Vorsprung durch Technik: Evolution, implementation, QA and safety of new technology in radiotherapy
    Author(s) unavailable

    Radiother Oncol 94(2):4 (2010) PMID 20170973